| 000 | 01808 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515193029.0 | ||
| 264 | 0 | _c20100408 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2009.10.034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBílková, Eliska | |
| 245 | 0 | 0 |
_aTargeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cFeb 2010 |
||
| 300 |
_a1-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAspergillus niger _xenzymology |
| 650 | 0 | 4 | _aBuffers |
| 650 | 0 | 4 |
_aCellulases _xisolation & purification |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aChromatography, Gel |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 |
_aNystatin _xadministration & dosage |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 |
_aPropylene Glycols _xchemistry |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 700 | 1 | _aImramovský, Ales | |
| 700 | 1 | _aBuchta, Vladimír | |
| 700 | 1 | _aSedlák, Milos | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 386 _gno. 1-2 _gp. 1-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2009.10.034 _zAvailable from publisher's website |
| 999 |
_c19263767 _d19263767 |
||